文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

糖胺聚糖对脓毒症患者血管内皮糖萼影响的临床研究

[Clinical study on the effect of glycosaminoglycans on vascular endothelial glycocalyx in sepsis].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2025-01-01
一句话结论脓毒症患者加用糖胺聚糖(舒洛地特2 mL肌内注射每日1次共7天)可降低内皮糖萼降解产物HS与SDC-1水平、降低SOFA评分并缩短住院时间,但ICU与28天死亡率无显著差异。

该前瞻性研究纳入杭州师范大学附属医院ICU 2022年12月至2023年12月收治的50例成人脓毒症患者,随机分为常规治疗组(25例)与GAG干预组(25例),两组均按2021年拯救脓毒症运动指南治疗,GAG干预组额外给予舒洛地特2 mL肌内注射每日1次共7天。结果显示GAG干预组72小时与7天HS水平、6至72小时及7天SDC-1水平显著低于常规组,治疗48小时与7天SOFA评分显著低于常规组,7天CRP显著低于常规组,住院时间显著缩短;两组ICU与28天死亡率无统计学显著差异。ROC分析显示HS、CRP、APTT、IL-6、APACHE II、SOFA、ISTH评分为预后预测因素,多指标联合预测AUC=0.911(95%CI 0.817-1.000),敏感度76.9%、特异度91.9%。

要点

  • 50例成人脓毒症患者随机分为常规组25例与GAG干预组25例,GAG干预组在2021年拯救脓毒症运动指南治疗基础上加用舒洛地特2 mL肌内注射每日1次共7天。
  • GAG干预组72小时与7天HS水平、6、24、48、72小时及7天SDC-1水平显著低于常规治疗组,提示内皮糖萼降解减轻。
  • GAG干预组治疗48小时与7天SOFA评分显著低于常规组,7天CRP显著低于常规组,住院时间显著短于常规组。
  • 两组ICU与28天死亡率无统计学显著差异;GAG干预组72小时PT较常规组显著延长。
  • HS、CRP、APTT、IL-6、APACHE II、SOFA、ISTH评分为脓毒症预后预测因素,多指标联合预测AUC=0.911(95%CI 0.817-1.000),敏感度76.9%、特异度91.9%。

适用人群与场景

  • 杭州师范大学附属医院ICU 2022年12月至2023年12月收治的符合纳入标准的成人脓毒症患者50例。

诊断标准与关键阈值

  • 采用APACHE II评分、SOFA评分及ISTH评分评估病情严重程度与凝血状态。

处置流程与药物剂量

  • 两组均按2021年拯救脓毒症运动指南进行常规治疗。
  • GAG干预组在常规治疗基础上加用糖胺聚糖(舒洛地特)2 mL肌内注射,每日1次,疗程7天。
  • 入组后0、6、24、48、72小时及7天采集静脉血检测HS、SDC-1、CRP、PCT、TNF-α、IL-6、PT、APTT、AT-III、Fib、D-二聚体,并进行APACHE II、SOFA、ISTH评分。

研究设计与关键结果

  • 前瞻性研究,纳入50例成人脓毒症患者,常规治疗组25例与GAG干预组25例;两组均按2021年拯救脓毒症运动指南治疗,GAG干预组加用舒洛地特2 mL肌内注射每日1次共7天。
  • 与基线相比两组HS与SDC-1水平均呈升高趋势;GAG干预组72小时与7天HS水平、6、24、48、72小时及7天SDC-1水平显著低于常规组。
  • 存活患者中,GAG干预组72小时HS水平与6小时SDC-1水平较常规组显著降低。
  • GAG干预组治疗7天后APACHE II、SOFA、ISTH评分较治疗前显著下降;治疗48小时与7天SOFA评分显著低于常规组。
  • GAG干预组治疗48小时后IL-6水平较治疗前显著下降;两组CRP随治疗时间延长显著下降,7天时GAG干预组CRP显著低于常规组。
  • 随治疗时间延长两组PT、APTT呈升高趋势、Fib呈下降趋势;GAG干预组72小时PT较常规组显著延长。
  • 两组ICU与28天死亡率无统计学显著差异;GAG干预组住院时间显著短于常规组。
  • ROC分析示HS、CRP、APTT、IL-6、APACHE II、SOFA、ISTH评分为脓毒症预后预测因素(均P<0.05);多指标联合预测AUC=0.911(95%CI 0.817-1.000),敏感度76.9%、特异度91.9%。

证据类型、等级与局限

  • 证据类型:前瞻性研究,单中心,样本量50例。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 脓毒症患者早期即可出现糖萼降解;作者认为GAG对血管内皮有保护作用,可减轻脓毒症严重程度并提供器官保护。
  • HS、CRP、APTT、IL-6、APACHE II评分、SOFA评分、ISTH评分为脓毒症预后预测因素,HS与上述指标联合可显著提高预测准确性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To explore the protective effect of glycosaminoglycans (GAG) on vascular endothelium in patients with sepsis.

METHODS: A prospective study was conducted on adult patients with sepsis admitted to the intensive care unit (ICU) of Hangzhou Normal University Affiliated Hospital from December 2022 to December 2023. Patients were randomly divided into conventional treatment group and GAG intervention group. Both groups were treated according to the 2021 Surviving Sepsis Campaign Guidelines. The GAG intervention group was additionally treated with GAG (2 mL of sulodexide intramuscular injection once daily for 7 days) on the basis of conventional treatment. Venous blood was collected from patients at 0, 6, 24, 48, 72 hours and 7 days after enrollment to detect serum vascular endothelial glycocalyx [heparan sulfate (HS) and syndecan-1 (SDC-1)], inflammatory markers [C-reactive protein (CRP), procalcitonin (PCT), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6)], and coagulation markers [prothrombin time (PT), activated partial thromboplastin time (APTT), antithrombin-III (AT-III), fibrinogen (Fib), D-Dimer], and to perform acute physiology and chronic health evaluation II (APACHE II), sequential organ failure assessment (SOFA), and International Society on Thrombosis and Haemostasis (ISTH) scores. The prognosis of patients (length of hospital stay, ICU and 28-day mortality) was observed. The receiver operator characteristic curve (ROC curve) was drawn to evaluate the value of HS in predicting the prognosis of sepsis patients, and the correlation between endothelial glycocalyx degradation products and various clinical indicators was analyzed.

RESULTS: A total of 50 adult patients with sepsis meeting the inclusion criteria were enrolled, with 25 in the conventional treatment group and 25 in the GAG intervention group. In terms of degradation products of endothelial glycocalyx, compared to baseline, both groups showed an increasing trend in HS and SDC-1 levels post-treatment. However, the GAG intervention group exhibited significantly lower HS levels at 72 hours and 7 days, as well as lower SDC-1 levels at 6, 24, 48, 72 hours and 7 days compared to the conventional group. Among the surviving patients, the HS levels at 72 hours and SDC-1 levels at 6 hours of treatment in the GAG intervention group were significantly reduced compared to the conventional treatment group. In terms of severity score, compared with before treatment, the GAG intervention group showed a significant decrease in APACHE II, SOFA, and ISTH scores after 7 days of treatment. The SOFA scores of the GAG intervention group after 48 hours and 7 days of treatment were significantly lower than those of the conventional treatment group. In terms of inflammatory indicators, compared with before treatment, the GAG intervention group showed a significant decrease in IL-6 levels after 48 hours of treatment. With the prolongation of treatment time, the CRP levels of both groups of patients showed a significant downward trend, and at 7 days of treatment, the CRP level in the GAG intervention group was significantly lower than that in the conventional treatment group. In terms of coagulation function, with prolonged treatment time, PT and APTT of both groups of patients showed an increasing trend, while Fib showed a decreasing trend. The GAG intervention group showed a significant prolongation of PT after 72 hours of treatment compared to the conventional treatment group. In terms of prognosis, there were no statistically significant differences in ICU and 28-day mortality rates between the two groups. The GAG intervention group had significantly shorter hospital stays than the conventional treatment group. ROC curve analysis showed that HS, CRP, APTT, IL-6, APACHE II, SOFA, and ISTH scores were predictive factors for the prognosis of sepsis patients (all P < 0.05). Compared to a single indicator, the combined detection of multiple indicators has a higher value in predicting the prognosis of sepsis patients [area under the curve (AUC) = 0.911, 95% confidence interval (95%CI) was 0.817-1.000], with a sensitivity of 76.9% and a specificity of 91.9%. Correlation analysis showed that HS was significantly negatively correlated with Fib, PT, TNF-α, IL-6, and PCT (r values were -0.338, -0.396, -0.288, -0.319, and -0.340, all P < 0.05), while HS was significantly positively correlated with D-Dimer and CRP (r values were 0.347 and 0.354, both P < 0.05); SDC-1 was significantly negatively correlated with Fib, PT, APTT, TNF-α, IL-6, and ISTH scores (r values were -0.314, -0.294, -0.408, -0.353, -0.289, -0.287, all P < 0.05).

CONCLUSIONS: Early glycocalyx degradation can occur in sepsis patients. GAG have a protective effect on,the vascular endothelium, reducing the severity of sepsis and providing organ protection. HS, CRP, APTT, IL-6, APACHE II score, SOFA score, and ISTH score are independent predictive factors for the prognosis of sepsis patients. The combination of HS and the above indicators can significantly improve the accuracy of prediction.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Tang Z, Guo L, Zhang Z, et al. [Clinical study on the effect of glycosaminoglycans on vascular endothelial glycocalyx in sepsis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 40820527. doi:10.3760/cma.j.cn121430-20240725-00634

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。